Cargando…
Involvement of GABA Transporters in Atropine-Treated Myopic Retina As Revealed by iTRAQ Quantitative Proteomics
[Image: see text] Atropine, a muscarinic antagonist, is known to inhibit myopia progression in several animal models and humans. However, the mode of action is not established yet. In this study, we compared quantitative iTRAQ proteomic analysis in the retinas collected from control and lens-induced...
Autores principales: | Barathi, Veluchamy A., Chaurasia, Shyam S., Poidinger, Michael, Koh, Siew Kwan, Tian, Dechao, Ho, Candice, Iuvone, P. Michael, Beuerman, Roger W., Zhou, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227558/ https://www.ncbi.nlm.nih.gov/pubmed/25211393 http://dx.doi.org/10.1021/pr500558y |
Ejemplares similares
-
Comparison of iTRAQ and SWATH in a clinical study with multiple time points
por: Jylhä, Antti, et al.
Publicado: (2018) -
Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: Prior to and after induction of experimental myopia with atropine treatment
por: Barathi, V.A., et al.
Publicado: (2011) -
Short-Term Effects of Atropine 0.01% on the Structure and Vasculature of the Choroid and Retina in Myopic Chinese Children
por: Wang, Yuliang, et al.
Publicado: (2022) -
Combined retinal proteome datasets in response to atropine treatment using iTRAQ and SWATH-MS based proteomics approaches in guinea pig myopia model
por: Zhu, Ying, et al.
Publicado: (2020) -
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005)